Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this category‘The centre of gravity for Southeast Asia’ – why PE investment is making Singapore increasingly attractiveLaw firmsKate Peacock8 May 2026Legal Business Awards 2026: which firms made the shortlist?Law firmsNews Editor7 May 2026Elite trio prompt Anthropic’s $1.5bn JV with Blackstone, Hellman and GoldmanLaw firmsTom Cox5 May 2026Ashurst EMEA energy and infrastructure M&A head set to join Vinson’s City baseLaw firmsWill Lewallen11 May 2026Latham and Davis Polk gear up for $2bn Lime IPOLaw firmsWill Lewallen11 May 2026Akin hires four-partner Sidley private equity team across NY and LondonLaw firmsWill Lewallen8 May 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025